Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5644-5651

  Abraham, Edward ^a   Gyetko, Margaret R ^b   Kuhn, Katherine ^a   Arcaroli, John ^a   Strassheim, Derek ^a   Park, Jong Sung ^a   Shetty, Sreerama ^c   Idell, Steven ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PLASMIN; PLASMINOGEN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG EDEMA; LUNG INJURY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; TRANSGENIC MOUSE;

EID: 0037851743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5644     Document Type: Article

References (56)

1. Rijneveld, A. W., M. Levi, S. Florquin, P. Speelman, P. Carmeliet, and T. van der Poll. 2002. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J. Immunol. 168:3507.
2. 2 integrins in vivo. J. Exp. Med. 188:1029.
3. Hansen, A. P., A. M. Petros, R. P. Meadows, D. G. Nettesheim, A. P. Mazar, E. T. Olejniczak, R. X. Xu, T. M. Pederson, J. Henkin, and S. W. Fesik. 1994. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 33:4847.
4. Vassalli, J., A. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067.
5. Takahashi, K. Y. Uwabe, Y. Sawasaki, T. Kiguchi, H. Nakamura, K. Kashiwabara, H. Yagyu, and T. Matsuoka. 1998. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 275:L47.
6. Marshall, B. C., Q.-P. Xu, N. V. Rao, B. R. Brown, and J. R. Hoidal. 1992. Pulmonary epithelial cell urokinase-type plasminogen activator: induction by interleukin-1β and tumor necrosis factor-α. J. Biol. Chem. 267:11462.
7. Plesner, T., M. Ploug, V. Ellis, E. Ronne, G. Hoyer-Hansen, M. Wittrup, T. L. Pedersen, T. Tscherning, K. Dano, and N. D. Hansen. 1994. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83:808.
8. Mukhina, S., V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, A. Shevelev, and V. Tkachuk. 2000. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. J. BioL Chem. 275:16450.
9. Resnati, M., M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1572.
10. Gyetko, M. R., R. G. Sitrin, J. A. Fuller III, R. F. Todd, H. Petty, and T. J. Standiford. 1995. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leukocyte Biol. 58:533.
11. Quax, P. H. A., J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, B. W. M. van Hinsbergh, and J. H. Verheijen. 1998. Binding of human urokinase-type plasminogen activator to its receptor. Arterioscler. Thromb. Vasc. Biol. 18:693.
12. Boyle, M. D., V. A. Chiodo, M. J. Lawman, A. P. Gee, and M, Young. 1987. Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 139:169.
13. Gudewicz, P. W., and N. Gilboa. 1987. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochim. Biophys. Acta 147:1176.
14. Beck, J. M., A. M. Preston, and M. R. Gyetko. 1999. Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice. Infect. Immun. 67:879.
15. Blasi, F. 1997. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today 18:415.
16. Dumler, I., T. Petri, and W. D. Schleuning. 1993. Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (uPAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett. 322:37.
17. Cohen, S. D., E. Israil, B. Spiess-Meier, and M. A. Wainberg. 1981. Plasminogen activator is an apparent lymphocyte mitogen. J. Immunol. 126:1415.
18. Sitrin, R. G., S. B. Shollenberger, R. M. Strieter, and M. R. Gyetko. 1996. Endogenously produced urokinase activity amplifies tumor necrosis factor-α secretion by THP-1 mononuclear phagocytes. J. Leukocyte Biol. 59:302.
19. Odekon, L. E., N. Gilboa, P. Del Vecchio, and P. W. Gudewicz. 1992. Urokinase in conditioned medium from phorbol ester-pretreated endothelial cells promotes polymorphonuclear leukocyte migration. Circ. Shock 37:169.
20. Robbie, L. A., S. Dummer, N. A. Booth, G. D. Adey, and B. Bennett. 2000. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leukocytes in patients with severe sepsis. Br. J. Haematol. 109:342.
21. Braat, E. A., U. Nauland, G. Dooijewaard, and D. C. Rijken. 1996. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids. Thromb. Haemostasis 75:908.
22. Philippe, J., F. Offner, P. J. Declerck, G. Leroux-Roels, D. Vogelaers, G. Baele, and D. Collen. 1991. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb. Haemostasis 65:291.
23. Gyetko, M., S. Shollenberger, and R. Sitrin. 1992. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon γ and tumor necrosis factor-α. J. Leukocyte Biol. 51:256.
24. Vaday, G. G., and O. Lider. 2000. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J. Leukocyte. Biol. 67:149.
25. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage of endotoxemia induced acute lung injury. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 279:L1137.
26. Yum, H.-K., J. Arcaroli, J. Kupfner, R. Shenkar, J. M. Penninger, T. Sasaki, K.-Y. Yang, J. S. Park, and E. Abraham. 2001. Involvement of PI3-K in neutrophil activation and the development of acute lung injury. J. Immunol. 167:6601.
27. Nick, J. A., N. J. Avdi, S. K. Young, L. A. Lehman, P. P. McDonald, S. C. Frasch, M. A. Billstrom, P. M. Henson, G. L. Johnson, and G. S. Worthen. 1999. Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. Clin. Invest. 103:851.
28. Sabroe, I., E. C. Jones, L. R. Usher, M. K. Whyte, and S.K. Dower. 2002. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168:4701.
29. Parsey, M. V., R. Tuder, and E. Abraham. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J. Immunol. 160:1007.
30. Abraham, E., D. J. Kaneko, and R. Shenkar. 1999. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am. J. Physiol. 276:L1.
31. Gyetko, M. R., G. H. Chen, R. A. McDonald, R. Goodman, G. B. Huffnagle, C. C. Wilkinson, J. A. Fuller, and G. B. Toews. 1996. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: A murine transgenic model. J. Clin. Invest. 97:1818.
32. Gyetko, M. R., S. Sudha, G.-H. Chen, J. A. Fuller, S. W. Chensue, and G. B. Toews. 2002. Urokinase-type plasminogen activator is required for the generation of a type I immune response to pulmonary Cryptococcus neoformans infection. J. Immunol. 168:801.
33. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford. 2000. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165:1513.
34. Herren, T., T. A. Burke, M. Jardi, J. Felez, and E. F. Plow. 2001. Regulation of plasminogen binding to neutrophils. Blood 97:1070.
35. Cao, D., I. F. Mizukami, B. A. Gami-Wagner, A. L. Kindzelskii III, R. F. Todd, L. A. Boxer, and H. R. Petty. 1995. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. J. Immunol. 154:1817.
36. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419.
37. Kubo, H., D. Morgenstern, W. M. Quinlan, P. A. Ward, M. C. Dinauer, and C. M. Doershuk. 1996. Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase. J. Clin. Invest. 97:2680.
38. Abraham, E., J. Arcaroli, H.-K. Yum, J. P. Park, and K.-Y. Yang. 2002. Effects of catecholamines on acute lung injury and kinase activation in lung neutrophils after hemorrhage or endotoxemia. J. Leukocyte Biol. 72:571.
39. Avdi, N. J., J. A. Nick, B. B. Whitlock, M. A. Billstrom, P. M. Henson, G. L. Johnson, and G. S. Worthen. 2001. Tumor necrosis factor-α activation of the c-Jun N-terminal kinase pathway in human neutrophils. J. Biol. Chem. 276:2189.
40. Rane, M. J., S. L. Carrithers, J. M. Arthur, J. B. Klein, and K. R. McLeish. 1997. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase C cascades by distinct signal transduction pathways. J. Immunol. 159:5070.
41. Rameh, L. E., and L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347.
42. Dekker, L. V., and A. W. Segal. 2000. Perspectives: signal transduction: signals to move cells. Science 287:982.
43. Thelen, M., and S. A. Didichenko. 1997. G-protein coupled receptor-mediated activation of PI 3-kinase in neutrophils. Ann. NY Acad Sci. 832:368.
44. Toker, A. 2000. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57:652.
45. Li, Z., H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka, and D. Wu. 2000. Role of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287:1046.
46. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Momovani, F. Altruda, and M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287:1049.
47. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al. 2000. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration, Science 287:1040.
48. Srivastava, S., M. N. Weitzmann, S. Cenci, F. P. Ross. S. Adler, and R. Pacifici. 1999. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104:503.
49. Koyama, Y., Y. Tanaka, K. Saito, M. Abe, K. Nakatsuka, I. Morimoto, P. E. Auron, and S. Eto. 1996. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1β transcription. J. Immunol. 157:5097.
50. Estreicher, A., A. Wohlwend. D. Belin, W.-D. Schleuning, and J.-D. Vassalli. 1989. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264:1180.
51. Matsushima, K., M. Taguchi, E. J. Kovacs, H. A. Young, and J. J. Oppenheim. 1986. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J. Immunol. 136:2883.
52. Robson, S. C., R. Saunders, and R. E. Kirsch. 1990. Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors. J. Clin. Lab. Immunol. 33:83.
53. Biemond, B. J., M. Levi, H. Ten Cate, T. van der Poll, H. R. Buller, C. E. Hack, and J. W. Ten Cate. 1995. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin. Sci. 88:587.
54. Idell, S., B. T. Peterson, K. K. Gonzalez, L. D. Gray, R. Bach, J. McLarty, and D. S. Fair. 1988. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury. Am. Rev. Respir. Dis. 138:1282.
55. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322:890.
56. Idell, S. 2002. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit. Care Med. 30:S274.